A carregar...
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
The goals of COPD therapy are to prevent and control symptoms, reduce the frequency and severity of exacerbations, and improve exercise tolerance. The triple combination therapy of inhaled corticosteroids (ICSs), long-acting beta(2) agonists (LABAs), and long-acting muscarinic antagonists (LAMAs) ha...
Na minha lista:
Publicado no: | Int J Chron Obstruct Pulmon Dis |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5638574/ https://ncbi.nlm.nih.gov/pubmed/29062229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S146822 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|